Michael Prados
Impact in
Papers in
- Genetics 32
- Glioma Diagnosis and Treatment 30
- Co-authors
- Michael S. B. EdwardsVictor A. LevinEric BurtonJane RabbittJoseph PetronioPamela SilverKathleen R. LambornTimothy F. Cloughesy
- Journals
- Journal of Clinical Oncology (11 papers)Neuro-Oncology (8 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Molecular Cancer Therapeutics (2 papers)Neurosurgery (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Michael Prados
39 papers receiving 775 citations
Peers
Comparison fields: 5 of 63
- Genetics 522
- Neurology 228
- Cancer Research 105
- Pulmonary and Respiratory Medicine 206
- Oncology 152
Countries citing papers authored by Michael Prados
This map shows the geographic impact of Michael Prados's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Prados with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Prados more than expected).
Fields of papers citing papers by Michael Prados
This network shows the impact of papers produced by Michael Prados. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Prados. The network helps show where Michael Prados may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Prados, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2016 | 21 | |
| 6 | 2011 | 76 | |
| 7 | 2010 | 61 | |
| 8 | 2009 | 36 | |
| 9 | 2009 | 31 | |
| 10 | Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma | 2007 | 1 |
| 11 | Autologous tumor derived gp96 evokes a tumor specific immune response in recurrent glioma patients that correlates with clinical response to therapy | 2007 | 9 |
| 12 | 2005 | 14 | |
| 13 | 1999 | 44 | |
| 14 | 1997 | 30 | |
| 15 | 1997 | 19 | |
| 16 | 1995 | 58 | |
| 17 | 1995 | 70 | |
| 18 | 1991 | 39 | |
| 19 | 1991 | 135 | |
| 20 | 1987 | 25 |
About Michael Prados
Michael Prados is a scholar working on Genetics, Structural Biology, Oncology, Cancer Research and Ophthalmology, having authored 39 papers that have together received 794 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (30 papers), Cancer Treatment and Pharmacology (6 papers), Brain Metastases and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Neuroblastoma Research and Treatments (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Melanoma and MAPK Pathways (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Genetics (522 citations), Neurology (228 citations), Cancer Research (105 citations), Pulmonary and Respiratory Medicine (206 citations) and Oncology (152 citations). Michael Prados has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Michael S. B. Edwards, Victor A. Levin, Eric Burton, Jane Rabbitt, Joseph Petronio, Pamela Silver, Kathleen R. Lamborn, Timothy F. Cloughesy, Philip H. Gutin and Susan M. Chang. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, International Journal of Radiation Oncology*Biology*Physics, Molecular Cancer Therapeutics and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.